13 WTHR - Indianapolis News |Threshold Pharmaceuticals 3Q loss widens on costs

Threshold Pharmaceuticals 3Q loss widens on costs

Posted: Updated:

REDWOOD CITY, Calif. (AP) - Threshold Pharmaceuticals Inc., a development-stage biotechnology company, said late Thursday its third-quarter loss widened on higher research, development, and interest expenses.

The company lost $6.2 million, or 40 cents per share, compared with a loss of $4.6 million, or 49 cents per share, during the year-ago period.

Threshold reported no revenue, compared with $362,000 a year prior.

Operating expenses rose 4 percent to $5.2 million as the company continued developing its potential cancer treatment TH-302. Meanwhile, interest expense surged to $957,000 from $13,000.

Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Powered by WorldNow
All content © Copyright 2002 - 2010 WorldNow and WTHR. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.It is the policy of The Dispatch Broadcast Group to provide equal employment opportunity to all qualified individuals without regard to their race, color, religion, national origin, age, sex, marital status, disability, military status, citizenship or any other legally-protected status in accordance with applicable local, state and federal law. Jobs at WTHR EEO Public File Report